By Julia Werdigier Novartis, one of Switzerland’s biggest drug makers, said Tuesday it scrapped a planned $78 million payment to its departing chairman because of
By Richard Teitelbaum Amid a storm of criticism, government investigations and an SEC suit, the investment bank’s outside directors have failed to speak out. Greg
The Newspaper Crash Undernews | 06 February 2013 Print newspaper readership ranged from 16% of forty-somethings to only… Libor Accords Leave Banks Facing ‘Massive’ State